Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis

Cheng-Chia Lee, Cheng-Hao Weng, Wen-Hung Huang, Tzung-Hai Yen, Ja-Liang Lin, Dan-Tzu Lin-Tan, Kuan-Hsing Chen, Ching-Wei Hsu, Cheng-Chia Lee, Cheng-Hao Weng, Wen-Hung Huang, Tzung-Hai Yen, Ja-Liang Lin, Dan-Tzu Lin-Tan, Kuan-Hsing Chen, Ching-Wei Hsu

Abstract

The negative impact of environmental exposure of cadmium has been well established in the general population. However, the effect of cadmium exposure in chronic peritoneal dialysis (PD) patients remains uncertain.A total of 306 chronic PD patients were included in this 36-month observational study. Patients were stratified into 3 groups by the tertile of baseline blood cadmium levels (BCLs): high (>0.244 μg/L, n = 101), middle (0.130-0.244 μg/L, n = 102), and low (<0.130 μg/L, n = 103) for cross-sectional analyses. Mortality rates and cause of death were recorded for longitudinal analyses.Patients in the high-BCL group were older, more likely to have diabetes mellitus, had lower levels of serum albumin and lower percentage of lean body mass than patients in the low-BCL group. A multivariate logistic regression analysis revealed that logarithmic transformed BCL was independently associated with a higher risk of low turnover bone disease (odds ratio = 3.8, P = 0.005). At the end of the 36-month follow-up, 66 (21.6%) patients died. Mortality rates increased with higher BCLs (P for trend = 0.005). A Cox multivariate analysis showed that, using the low-BCL group as the reference, the high-BCL group had increased hazard ratios (HR) for all-cause mortality in chronic PD patients after adjusting for related variables (HR = 2.469, 95% confidence interval = 1.078-5.650, P = 0.043).In conclusion, BCL showed significant association with malnutrition and low turnover bone disease in chronic PD patients. Furthermore, BCL is an important determinant of mortality. Our findings suggest that avoiding environmental exposure to cadmium as much as possible is warranted in chronic PD patients.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Percentage of patients with low turnover bone disease (defined by serum levels of intact parathyroid hormone

References

    1. Jarup L, Berglund M, Elinder CG, et al. Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 1998; (24 Suppl 1):1–51.
    1. Arisawa K, Nakano A, Saito H, et al. Mortality and cancer incidence among a population previously exposed to environmental cadmium. Int Arch Occup Environ Health 2001; 74:255–262.
    1. Akesson A, Barregard L, Bergdahl IA, et al. Non-renal effects and the risk assessment of environmental cadmium exposure. Environ Health Perspect 2014; 122:431–438.
    1. Nakagawa H, Nishijo M, Morikawa Y, et al. Urinary cadmium and mortality among inhabitants of a cadmium-polluted area in Japan. Environ Res 2006; 100:323–329.
    1. Li Q, Nishijo M, Nakagawa H, et al. Relationship between urinary cadmium and mortality in habitants of a cadmium-polluted area: a 22-year follow-up study in Japan. Chin Med J (Engl) 2011; 124:3504–3509.
    1. Tellez-Plaza M, Navas-Acien A, Menke A, et al. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect 2012; 120:1017–1022.
    1. Barregard L, Sallsten G, Fagerberg B, et al. Blood cadmium levels and incident cardiovascular events during follow-up in a population-based cohort of Swedish adults: The Malmö Diet and Cancer Study. Environ Health Perspect 2016; 124:594–600.
    1. Messner B, Knoflach M, Seubert A, et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009; 29:1392–1398.
    1. Turdi S, Sun W, Tan Y, et al. Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies. Clin Exp Pharmacol Physiol 2013; 40:706–712.
    1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112–S119.
    1. D’Haese PC, Couttenye MM, Lamberts LV, et al. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 1999; 45:1548–1556.
    1. Vanholder R, Cornelis R, Dhondt A, et al. The role of trace elements in uraemic toxicity. Nephrol Dial Transplant 2002; (17 Suppl 2):2–8.
    1. Chen B, Lamberts LV, Behets GJ, et al. Selenium, lead, and cadmium levels in renal failure patients in China. Biol Trace Elem Res 2009; 131:1–12.
    1. Hsu CW, Yen TH, Chen KH, et al. Effect of blood cadmium level on mortality in patients undergoing maintenance hemodialysis. Medicine 2015; 94:e1755.
    1. Hsu CW, Lin JL, Lin-Tan DT, et al. Association of environmental cadmium exposure with inflammation and malnutrition in maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24:1282–1288.
    1. Kazi TG, Jalbani N, Kazi N, et al. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis. Ren Fail 2008; 30:737–745.
    1. Wang M, Hercz G, Sherrard DJ, et al. Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995; 26:836–844.
    1. Lin JL, Lin-Tan DT, Chu PH, et al. Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients. Crit Care Med 2009; 37:957–962.
    1. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976; 29:1359–1366.
    1. Fransson MN, Barregard L, Sallsten G, et al. Physiologically-based toxicokinetic model for cadmium using Markov-chain Monte Carlo analysis of concentrations in blood, urine, and kidney cortex from living kidney donors. Toxicol Sci 2014; 141:365–376.
    1. Olsson IM, Bensryd I, Lundh T, et al. Cadmium in blood and urine–impact of sex, age, dietary intake, iron status, and former smoking–association of renal effects. Environ Health Perspect 2002; 110:1185–1190.
    1. Nawrot TS, Van Hecke E, Thijs L, et al. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect 2008; 116:1620–1628.
    1. Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition–inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42:864–881.
    1. Lin YS, Rathod D, Ho WC, et al. Cadmium exposure is associated with elevated blood C-reactive protein and fibrinogen in the U. S. population: the third national health and nutrition examination survey (NHANES III, 1988–1994). Ann Epidemiol 2009; 19:592–596.
    1. Colacino JA, Arthur AE, Ferguson KK, et al. Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress. Environ Res 2014; 131:6–12.
    1. Cuypers A, Plusquin M, Remans T, et al. Cadmium stress: an oxidative challenge. Biometals 2010; 23:927–940.
    1. Navas-Acien A, Selvin E, Sharrett AR, et al. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004; 109:3196–3201.
    1. Fagerberg B, Barregard L, Sallsten G, et al. Cadmium exposure and atherosclerotic carotid plaques—results from the Malmo diet and Cancer study. Environ Res 2015; 136:67–74.
    1. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine 2009; 88:154–159.
    1. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47:182–187.
    1. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, et al. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274–284.
    1. El-Boshy ME, Risha EF, Abdelhamid FM, et al. Protective effects of selenium against cadmium induced hematological disturbances, immunosuppressive, oxidative stress and hepatorenal damage in rats. J Trace Elem Med Biol 2015; 29:104–110.
    1. Carmen Sanchez M, Auxiliadora Bajo M, Selgas R, et al. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. Am J Kidney Dis 2000; 36:953–961.
    1. Levy R, Gal-Moscovici A. Renal osteodystrophy in peritoneal dialysis: special consideration. Perit Dial Int 2008; (28 Suppl 2:)S11–S19.
    1. Åkesson A, Bjellerup P, Lundh T, et al. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 2006; 114:830–834.
    1. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70:771–780.
    1. Dukkipati R, Kovesdy CP, Colman S, et al. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 2010; 20:243–254.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner